Veeva Systems Inc. (ETR:VEE)
208.80
+2.30 (1.11%)
At close: Dec 4, 2025
Veeva Systems Revenue
Veeva Systems had revenue of $811.24M USD in the quarter ending October 31, 2025, with 16.02% growth. This brings the company's revenue in the last twelve months to $3.08B, up 15.96% year-over-year. In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B with 16.20% growth.
Revenue (ttm)
$3.08B
Revenue Growth
+15.96%
P/S Ratio
12.80
Revenue / Employee
$422.47K
Employees
7,291
Market Cap
34.20B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
| Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
| Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
| Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
| Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
| Jan 31, 2020 | Pro | Pro | Pro |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.27B |
| Siemens Healthineers AG | 23.38B |
| Bayer Aktiengesellschaft | 45.87B |
| Fresenius SE & Co. KGaA | 22.45B |
| Sartorius Aktiengesellschaft | 3.52B |
| Fresenius Medical Care AG | 19.64B |
| Carl Zeiss Meditec AG | 2.18B |
| Fielmann Group AG | 2.42B |
Veeva Systems News
- 4 days ago - SA analyst upgrades/downgrades: AMD, VEEV, GRAB, INTC - Seeking Alpha
- 5 days ago - Veeva Systems: Unjustified Sell-Off, Justified Opportunity - Seeking Alpha
- 6 days ago - Burlington Stores, Oracle, Nutanix Are Among Top 10 Large Cap Losers Last Week (Nov. 24-Nov. 28): Are the Others in Your Portfolio? - Benzinga
- 7 days ago - 16 software stocks for investors sifting through the bargain bin - Market Watch
- 10 days ago - VEEV: Wells Fargo Lowers Price Target to $333 While Maintaining Overweight Rating | VEEV Stock News - GuruFocus
- 11 days ago - VEEV: Citigroup Lowers Price Target but Maintains Buy Rating | VEEV Stock News - GuruFocus
- 12 days ago - Veeva Announces Expanded Partnership with Roche - PRNewsWire
- 13 days ago - Veeva Systems: Sell-Off After Q3 Results Was Justified - Seeking Alpha